Insights

Access to New Cures & Innovative Care for Medicaid Patients 

Cell and gene therapies (CGTs) are some of the most promising and exciting medical advancements taking place today. Some existing CGTs treat previously untreatable rare diseases, and there are hundreds of CGTs in clinical development to treat various types of cancer, hemophilia, sickle cell and other blood disorders, Alzheimer’s disease, and numerous rare conditions. The … Read more

Leavitt Partners Releases “Florida Medicaid Expansion: Enrollment & Budget Forecasts” Report

Salt Lake City, September 30, 2019— Today, Leavitt Partners released a report entitled “Florida Medicaid Expansion: Enrollment & Budget Forecasts”, illustrating what the five-year enrollment and budgetary projections for full Medicaid Expansion in Florida beginning in 2020 could look like. The projections are based on a robust analysis and microsimulation modeling conducted by Leavitt Partners … Read more

Leavitt Partners Releases “The Medicaid ACO Landscape” White Paper

Salt Lake City, May 1, 2019—Today, Leavitt Partners released “The Medicaid ACO Landscape,” a white paper providing insight into the number, geographic dispersion, characteristics, and success of Medicaid ACOs as of the end of 2018. This snapshot of Medicaid ACOs was created using data from Torch Insight™, a proprietary analytics platform and compendium of health … Read more

Medicaid Closed Drug Formularies: A Closed Door or a Path Forward?

As we noted in July, CMS declined Massachusetts’ Medicaid 1115 demonstration request to establish a closed formulary.  The proposed program would have given Massachusetts the ability to exclude certain FDA-approved drugs from coverage and thereby given the state additional leverage in negotiating rebates.  The state and drug manufacturers would have otherwise continued to be subject to the rest of … Read more

Leavitt Partners Releases White Paper on “Value-Based Payment in Medicaid: Signals for States”

Salt Lake City, February 20, 2018 –Today, Leavitt Partners released “Value-Based Payment in Medicaid: Signals for States,” a white paper that outlines the Trump administration’s key signals to date and how they might impact state value-based payment (VBP) efforts in 2018 and beyond. States have grappled with many unanswered questions regarding the Trump administration’s views … Read more

The Medicare-Medicaid ACO Model: Addressing Dual Eligibles’ Costs

Dual eligibles, individuals enrolled in both Medicare and Medicaid, are among the highest-need, highest cost patients in the United States. Although it is difficult to determine the exact number of dual eligibles, a 2012 Kaiser Family Foundation report estimates that dual eligibles comprise 21 percent of the Medicare population and 15 percent of the Medicaid population. However, … Read more

The Future of Medicaid

The Affordable Care Act turned Medicaid into America’s largest public health care coverage program. While the volume associated with this growing program created increasing opportunities for providers, health systems, health plans, and vendors, these same stakeholders shouldn’t write off opportunities in Medicaid now simply because of the change in direction at the federal level. Instead, … Read more

CARIN Alliance and HHS Release Digital Identity Federation Report about their Test Proof of Concept

Washington, D.C., March 22, 2023 — The CARIN Alliance, a multi-sector collaborative of healthcare and other stakeholders working to advance the consumer-directed exchange of health information released a report today that lays the foundation for how individuals can voluntarily digital identity proof themselves once and use that same digital credential with multiple data holders of … Read more